Skip to main content

Attenuation of enoyl coenzyme A hydratase short chain 1 expression in gastric cancer cells inhibits cell proliferation and migration in vitro


Enoyl coenzyme A hydratase short chain 1 (ECHS1) is an important part of the mitochondrial fatty acid β-oxidation pathway. Altered ECHS1 expression has been implicated in cancer cell proliferation. This study assessed ECHS1 expression in human gastric cancer cell lines and investigated the effects of ECHS1 knockdown on gastric cancer cell proliferation and migration. The human gastric cancer cell lines SGC-7901, BGC-823 and MKN-28, and the immortalized human gastric epithelial mucosa GES-1 cell line were analyzed for ECHS1 protein levels using western blot. The effectiveness of ECHS1-RNA interference was also determined using western blot. Proliferation and migration of the siECHS1 cells were respectively measured with the CCK-8 and transwell assays. Phosphorylation of PKB and GSK3β was assessed using western blot. ECHS1 protein levels were significantly higher in poorly differentiated cells than in well-differentiated cells and immortalized gastric epithelial mucosa cells. Stable expression of ECHS1 shRNA was associated with an over 41% reduction in the ECHS1 protein levels of siECHS1 cells. Constitutive knockdown of the ECHS1 gene in siECHS1 cells was associated with significantly inhibited cell proliferation and migration. We also observed decreased levels of PKB and GSK3β phosphorylation in siECHS1 cells. ECHS1 expression is increased in human gastric cancer cells. Increased ECHS1 expression activates PKB and GSK3β by inducing the phosphorylation of the two kinases. ECHS1 may play important roles in gastric cancer cell proliferation and migration through PKB- and GSK3β-related signaling pathways.



cell counting kit-8


Dulbecco’s modified Eagle’s medium


enoyl coenzyme A hydratase short chain 1


ethylenediaminetetraacetic acid


fetal bovine serum


glycogen synthase kinase 3β


protein kinase B


signal transducer and activator of transcription 3


  1. Ferlay, J., Shin, H.R., Bray, F., Forman, D., Mathers, C. and Parkin, D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127 (2011) 2893–2917.

    Article  Google Scholar 

  2. Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E. and Forman, D. Global cancer statistics. CA Cancer J. Clin. 61 (2011) 69–90.

    Article  PubMed  Google Scholar 

  3. Guggenheim, D.E. and Shah, M.A. Gastric cancer epidemiology and risk factors. J. Surg. Oncol. 107 (2013) 230–236.

    Article  PubMed  Google Scholar 

  4. Lim, S.M., Lim, J.Y. and Cho, J.Y. Targeted therapy in gastric cancer: Personalizing cancer treatment based on patient genome. World J. Gastroenterol. 20 (2014) 2042–2050.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Cappetta, A., Lonardi, S., Pastorelli, D., Bergamo, F., Lombardi, G. and Zagonel, V. Advanced gastric cancer (GC) and cancer of the gastrooesophageal junction (GEJ): focus on targeted therapies. Crit. Rev. Oncol. Hematol. 81 (2012) 38–48.

    PubMed  Google Scholar 

  6. Vivanco, I. and Sawyers, C.L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2 (2002) 489–501.

    Article  CAS  PubMed  Google Scholar 

  7. Hennessy, B.T., Smith, D.L., Ram, P.T., Lu, Y. and Mills, G.B. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat. Rev. Drug Discov. 4 (2005) 988–1004.

    Article  CAS  PubMed  Google Scholar 

  8. Nam, S.Y., Lee, H.S., Jung, G.A., Choi, J., Cho, S.J., Kim, M.K., Kim, W.H. and Lee, B.L. AKT/PKB activation in gastric carcinomas correlates with clinicopathologic variables and prognosis. APMIS (Acta Pathol. Microbiol. Immunol. Scand.) 111 (2003) 1105–1113.

    Article  CAS  Google Scholar 

  9. Xu, J., Xu, P.J., Li Z.G., Xiao, L. and Yang, Z. The role of glycogen synthase kinase 3β in gloma cell apoptosis induced by remifentanil. Cell. Mol. Biol. Lett. 18 (2013) 494–506.

    Article  CAS  PubMed  Google Scholar 

  10. Kim, L. and Kimmel, A.R. GSK3, a master switch regul ating cell-fate specification and tumorigenesis. Curr. Opin. Genet. Dev. 10 (2000) 508–514.

    Article  CAS  PubMed  Google Scholar 

  11. Liu, J., Zhang, Y., Xu, R., Du, J., Hu, Z., Yang, L., Chen, Y., Zhu, Y. and Gu, L. PI3K/AKT-dependent phosphorylation of GSK3 beta and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration. Cell Signal. 25 (2013) 447–456.

    Article  CAS  PubMed  Google Scholar 

  12. Zhang, Z., Miao, L., Wu, X., Liu, G., Peng, Y., Xin, X., Jiao, B. and Kong, X. Carnosine inhibits the proliferation of human gastric carcinoma cells by retarding Akt/mTOR/p70S6K signaling. J. Cancer 5 (2014) 382–389.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Janssen, U., Davis, E.M., Le Beau, M.M. and Stoffel, W. Human mitochondrial enoyl-CoA hydratase gene (ECHS1): structural organization and assignment to chromosome 10q26.2–q26.3. Genomics 40 (1997) 470–475.

    Article  CAS  PubMed  Google Scholar 

  14. Liu, X., Feng, R. and Du, L. The role of enoyl-CoA hydratase short chain 1 and peroxiredoxin 3 in PP2-induced apoptosis in human breast cancer MCF-7 cells. FEBS Lett. 584 (2010) 3185–3192.

    Article  CAS  PubMed  Google Scholar 

  15. Yeh, C.S., Wang, J.Y., Cheng, T.L., Juan, C.H., Wu, C.H. and Lin, S.R. Fatty acid metabolism pathway play an important role in carcinogenesis of human colorectal cancers by microarray-bioinformatics analysis. Cancer Lett. 233 (2006) 297–308.

    Article  CAS  PubMed  Google Scholar 

  16. Lin, J.F., Xu, J., Tian, H.Y., Gao, X., Chen, Q.X., Gu, Q., Xu, G.J., Song, J.D. and Zhao, F.K. Identification of candidate prostate cancer biomarkers in prostate needle biopsy specimens using proteomic analysis. Int. J. Cancer 121 (2007) 2596–2605.

    Article  CAS  PubMed  Google Scholar 

  17. Hu, Y., Pang, E., Lai, P.B., Squire, J.A., MacGregor, P.F., Beheshti, B., Albert, M., Leung, T.W. and Wong, N. Genetic alterations in doxorubicinresistant hepatocellular carcinoma cells: a combined study of spectral karyotyping, positional expression profiling and candidate genes. Int. J. Oncol. 25 (2004) 1357–1364.

    CAS  PubMed  Google Scholar 

  18. Xiao, C.X., Yang, X.N., Huang, Q.W., Zhang, Y.Q., Lin, B.Y., Liu, J.J., Liu, Y.P., Jazag, A., Guleng, B. and Ren J.L. ECHS1 acts a s a novel HBsAg-binding protein enhancing apoptosis through the mitochondrial pathway in HepG2 cells. Cancer Lett. 330 (2013) 67–73.

    Article  CAS  PubMed  Google Scholar 

  19. Zhu, X.S., Dai, Y.C., Chen, Z.X., Xie, J.P., Zeng, W., Lin, Y.Y. and Tan, Q.H. Knockdown of ECHS1 protein expression inhibits hepatocellular carcinoma cell proliferation via suppression of AKT activity. Crit. Rev. Eukar. Gene Expr. 23 (2013) 275–282.

    Article  CAS  Google Scholar 

  20. Chang, Y., Wang, S.X., Wang, Y.B., Zhou, J., Li, W.H., Wang, N., Fang, D.F., Li, H.Y., Li, A.L., Zhang, X.M. and Zhang W.N. ECHS1 interacts with STAT3 and negatively regulates STAT3 signaling. FEBS Lett. 587 (2013) 607–613.

    Article  CAS  PubMed  Google Scholar 

  21. Vogt, P.K. and Hart, J.R. PI3K and STAT3: a new alliance. Cancer Discov. 1 (2011) 481–486.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Hart, J.R., Liao, L., Yates, J.R. 3rd. and Vogt, P.K. Essential role of Stat3 in PI3K-induced oncogenic transformation. Proc. Natl. Acad. Sci. USA 108 (2011) 13247–13252.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Miyagishi, M. and Taira, K. Strategies for generation of an siRNA expression library directed against the human genome. Oligonucleotides 13 (2003) 325–333.

    Article  CAS  PubMed  Google Scholar 

  24. Guo, Y., Kang, W., Lei, X., Li, Y., Xiang, A., Liu, Y., Zhao, J., Zhang, J. and Yan, Z. Hepatitis B viral core protein disrupts human host gene expression by binding to promoter regions. BMC Genomics 13 (2012) 563.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Gong, X., Zhu, Y., Dong, J., Chen, J., You, J., Zheng, Q., Rao, Z., Mao, Q. and Jiang, J. Small hepatitis B surface antigen interacts with and modulates enoyl-coenzyme A hydratase expression in hepatoma cells. Arch. Virol. 158 (2013) 1065–1070.

    Article  CAS  PubMed  Google Scholar 

  26. Yokoyama, Y., Kuramitsu, Y., Takashima, M., Iizuka, N., Toda, T., Terai, S., Sakaida, I., Oka, M., Nakamura, K. and Okita, K. Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus. Proteomics 4 (2004) 2111–2116.

    Article  CAS  PubMed  Google Scholar 

  27. Crous-Bou, M., Rennert, G., Salazar, R., Rodriguez-Moranta, F., Rennert, H.S., Lejbkowicz, F., Kopelovich, L., Lipkin, S.M., Gruber, S.B. and Moreno, V. Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer. Mutagenesis 27 (2012) 169–176.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Kurokawa, Y., Matoba, R., Takemasa, I., Nakamori, S., Tsujie, M., Nagano, H., Dono, K., Umeshita, K., Sakon, M., Ueno, N., Kita, H., Oba, S., Ishii, S., Kato, K. and Monden, M. Molecular features of non-B, non-C hepatocellular carcinoma: a PCR-array gene expression profiling study. J. Hepatol. 39 (2003) 1004–1012.

    Article  CAS  PubMed  Google Scholar 

  29. Vander Heiden, M.G., Cantley, L.C. and Thompson, C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324 (2009) 1029–1033.

    Article  Google Scholar 

  30. Kundu, J., Wahab, S.M., Kundu, J.K., Choi, Y.L., Erkin, O.C., Lee, H.S., Park, S.G. and Shin, Y.K. Tob1 induces apoptosis and inhibits proliferation, migration and invasion of gastric cancer cells by activating Smad4 and inhibiting betacatenin signaling. Int. J. Oncol. 41 (2012) 839–848.

    CAS  PubMed Central  PubMed  Google Scholar 

  31. Tang, X., Zheng, D., Hu, P., Zeng, Z., Li, M., Tucker, L., Monahan, R., Resnick, M.B., Liu, M. and Ramratnam, B. Glycogen synthase kinase 3 beta inhibits microRNA-183-96-182 cluster via the beta-catenin/TCF/LEF-1 pathway in gastric cancer cells. Nucleic Acids Res. 42 (2014) 2988–2998.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Xiao-San Zhu or Yi-Chen Dai.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhu, XS., Gao, P., Dai, YC. et al. Attenuation of enoyl coenzyme A hydratase short chain 1 expression in gastric cancer cells inhibits cell proliferation and migration in vitro. Cell Mol Biol Lett 19, 576–589 (2014).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


  • ECHS1
  • PKB
  • GSK3β
  • Gastric cancer
  • Cell proliferation
  • Cell migration
  • Interference
  • β-oxidation pathway
  • Signaling pathways
  • Cells